1985
DOI: 10.1016/0168-1656(85)90016-1
|View full text |Cite
|
Sign up to set email alerts
|

Enzymatic biosynthesis of ergotamine and investigation on some aminoacyl-tRNA synthetases in Claviceps

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
1

Year Published

1985
1985
1997
1997

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 23 publications
0
6
1
Order By: Relevance
“…It may be noted that work on the total cell-free synthesis of ergopeptines (Maier et al, 1981(Maier et al, , 1983(Maier et al, , 1985 yielded results that are quite different from those presented here. The most striking difference is that these authors found ergopeptine synthesis dependent on the biosynthetic precursors of D-lysergic acid, namely, agroclavine or elymoclavine, rather than on D-lysergic acid itself.…”
Section: Analysis Of Radioactive Lysergyl Peptides Besidescontrasting
confidence: 99%
“…It may be noted that work on the total cell-free synthesis of ergopeptines (Maier et al, 1981(Maier et al, , 1983(Maier et al, , 1985 yielded results that are quite different from those presented here. The most striking difference is that these authors found ergopeptine synthesis dependent on the biosynthetic precursors of D-lysergic acid, namely, agroclavine or elymoclavine, rather than on D-lysergic acid itself.…”
Section: Analysis Of Radioactive Lysergyl Peptides Besidescontrasting
confidence: 99%
“…In addition, the question as to which chemical form of the precursor of peptide-bound D-lysergic acidsi.e., either free D-lysergic acid, D-lysergyl Coenzyme A, or a simple clavinesmay serve as substrate in the assembly process remained a central controversial issue in these investigations. [152][153][154] Eventually the development of a cell-free system that incorporated exclusively free D-lysergic acid into the novel noncyclol peptide D-lysergyl-L-alanyl-L-phenylalanyl-L-proline lactam (Figure 14) provided the starting point to study D-lysergic acid peptide formation at the molecular level. 155 D-Lysergyl-L-alanyl-L-phenylalanyl-L-proline lactam has long been considered the immediate precursor of ergotamine.…”
Section: Ergot Peptide Alkaloidsmentioning
confidence: 99%
“…Various models for the mechanism of assembly of ergopeptines, elaborated from cell-free and in vivo data, have been proposed in the past. [152][153][154] They suggest unusual direction of peptide chain growth or free precursor peptides in the assembly of the Dlysergyl peptide backbonessuch as free D-lysergylalanine or D-lysergylvaline reacting with preformed prolyldiketopiperazinessobscuring the reaction mechanism of alkaloid cylopeptide formation. [152][153][154]162 Analysis of peptide intermediates accumulating on LPS 1 and LPS 2 in the presence of D-lysergic acid (or dihydrolysergic acid) and the amino acids of the alkaloid peptide chains shed light on the mode of the assembly of D-lysergyl peptides.…”
Section: Mechanism Of Formation Of D-lysergyl Peptide Lactammentioning
confidence: 99%
See 1 more Smart Citation
“…There was no ratio of 1 : 1 between covalently bound Phe to non-covalently bound phenylalanine as in the case of peptide antibiotics formation (LIPMANN 1971). This may be easily explained by the fact that ergotamine synthetase and phenylalanyl-tRNA synthetase are not separable by the used ion exchange chromatography (MAIER et al 1985). Thus most of the TCA-labile phenylalanine is attached to the Phe-tRNA synthetase.…”
mentioning
confidence: 99%